| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 2 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 4 | 2 | 3 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 5 | 4 | 3 | 5 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 2 |
| Expenses | 5 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA | -2 | -0 | 0 | -0 | 0 | 0 | 0 | -0 | 1 | -0 | 0 | 0 | 2 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | -159 % | -22 % | 6 % | -4 % | 7 % | 14 % | 4 % | -6 % | -11 % | -3 % | 6 % | 19 % | 4 % | 11 % | 19 % | 12 % | 16 % | 17 % | 5 % | 23 % | 18 % | 11 % | 19 % | 29 % | 30 % | 33 % | 26 % | 24 % | 26 % | 24 % | 24 % | 22 % | 33 % | 22 % | 32 % | 25 % | 30 % | 28 % | 31 % | 29 % |
| Depreciation | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -3 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | -0 | 1 | -0 | -0 | -0 | 2 | -0 | -0 | 0 | 0 | -0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Tax | -1 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -3 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | 1 | -1 | -1 | -0 | 1 | -0 | -0 | -0 | 1 | -0 | -0 | 0 | 0 | -0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| EPS in ₹ | -2.63 | -0.40 | -0.15 | -0.79 | -0.69 | -0.53 | -0.66 | -0.96 | 0.71 | -0.63 | -0.46 | -0.23 | 1.00 | -0.14 | -0.07 | -0.24 | 1.25 | -0.09 | -0.25 | 0.03 | 0.05 | -0.04 | 0.67 | 0.88 | 0.52 | 1.03 | 0.54 | 0.36 | 0.35 | 0.30 | 0.36 | 0.24 | 0.78 | 0.33 | 0.67 | 0.40 | 0.60 | 0.42 | 0.50 | 0.38 |
Medinova Diagnostic Service
38.02
-1.38
(-3.50%)
Market Cap
37.92 Cr
EPS
2.00
PE Ratio
20.74
Dividend Yield
0.00 %
Industry
Healthcare Services52 Week High
51.05
52 Week Low
30.66
PB Ratio
-18.04
Debt to Equity
0.00
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,478.80 | #1 20,720.72 | 50.13 | #1 2,295.80 | 11.52 | #1 362 | 19.34 | 43.44 | |
1,007.20 | 10,337.53 | 72.42 | 568.60 | 20.11 | 120 | 35.77 | 47.60 | |
1,564.55 | 8,023.19 | 53.44 | 1,216.80 | 4.59 | 129 | 15.38 | 34.43 | |
679.65 | 3,601.70 | 42.34 | 581.30 | 8.63 | 70 | 29.25 | 36.44 | |
787.90 | 2,544.11 | 34.57 | 636.40 | 25.65 | 57 | 49.23 | 52.38 | |
1,616.75 | 1,387.61 | 29.87 | 86.70 | 25.47 | 32 | 58.82 | 37.91 | |
242.42 | 771.15 | #1 7.43 | 1,436.10 | 35.04 | 6 | -1,081.25 | 49.93 | |
369.90 | 262.59 | 21.80 | 63.00 | #1 248.07 | 7 | 133.33 | 75.20 | |
85.23 | 87.69 | 109.40 | 13.60 | -8.11 | -3 | #1 142.86 | 51.49 | |
120.15 | 83.73 | 66.60 | 36.90 | 6.34 | 1 | 0.00 | 43.10 |
Growth Rate
Revenue Growth
1.96 %
Net Income Growth
17.65 %
Cash Flow Change
88.03 %
ROE
97.32 %
ROCE
-51.70 %
EBITDA Margin (Avg.)
4.01 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 10 | 13 | 9 | 6 | 5 | 4 | 4 | 4 | 5 | 5 |
| Fixed Assets | 7 | 9 | 7 | 5 | 3 | 2 | 2 | 2 | 2 | 2 |
| Current Assets | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4 | 4 | 2 | 2 | 1 | 2 | 3 | 3 | 3 | 4 |
| Total Liabilities | 10 | 13 | 9 | 6 | 5 | 4 | 4 | 4 | 5 | 5 |
| Current Liabilities | 15 | 13 | 11 | 10 | 9 | 9 | 8 | 5 | 4 | 3 |
| Non Current Liabilities | 2 | 8 | 7 | 6 | 5 | 5 | 4 | 6 | 6 | 5 |
| Total Equity | -7 | -8 | -10 | -10 | -9 | -9 | -8 | -7 | -5 | -3 |
| Reserve & Surplus | -16 | -18 | -20 | -20 | -19 | -19 | -17 | -17 | -15 | -13 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 1 |
| Investing Activities | -5 | -0 | 0 | -0 | -0 | -0 | -2 | -0 | -0 |
| Operating Activities | -1 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 3 |
| Financing Activities | 5 | 0 | -2 | -1 | -1 | -1 | 0 | -1 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 36.29 % | 36.05 % | 36.06 % | 36.19 % | 36.14 % | 36.01 % | 36.03 % | 35.96 % | 35.94 % | 36.00 % | 36.02 % | 35.49 % | 35.58 % | 36.09 % | 36.29 % | 35.90 % |
| Others | 1.57 % | 1.82 % | 1.80 % | 1.67 % | 1.73 % | 1.85 % | 1.83 % | 1.91 % | 1.93 % | 1.86 % | 1.84 % | 2.38 % | 2.28 % | 1.77 % | 1.58 % | 1.97 % |
| No of Share Holders | 9,494 | 9,582 | 9,804 | 9,906 | 9,860 | 9,900 | 9,937 | 9,972 | 9,926 | 9,921 | 10,041 | 10,205 | 10,295 | 10,544 | 10,730 | 10,931 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Closure of Trading Window
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoNotice Of Meeting Of The Equity Shareholders Of Medinova Diagnostic Services Limited To Be Convened As Per The Directions Provided In The Order Of The HonBle National Company Law Tribunal5 days ago
5 days agoIntimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Feb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Feb 01, 2025Integrated Filing (Financial)Jan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 30, 2025
Jan 30, 2025Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2025
Jan 30, 2025Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 23, 2025
Jan 23, 2025Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 Among Other Corporate Matters.Jan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Receipt Of Observation Letter From BSE Limited With No Adverse Observations For The Scheme Of AmalgamationDec 07, 2024
Dec 07, 2024Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Nov 16, 2024
Nov 16, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2024
Oct 30, 2024Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th October 2024Oct 29, 2024
Oct 29, 2024Un-Audited Financial Results For The Quarter Ended September 30, 2024Oct 29, 2024
Oct 29, 2024Board Meeting Intimation for To Consider And Approve The Standalone And Consolidated Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2024; And Other Corporate MattersOct 19, 2024
Oct 19, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 03, 2024
Oct 03, 2024Closure of Trading WindowSep 25, 2024
Sep 25, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 04, 2024
Sep 04, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 03, 2024
Sep 03, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2024
Aug 10, 2024Reg. 34 (1) Annual Report.Aug 09, 2024
Aug 09, 2024Notice Of 31St Annual General Meeting Of The CompanyAug 09, 2024
Aug 09, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2024
Aug 09, 2024Intimation Of 31St Annual General Meeting (AGM) And Cut-Off Date For E-Voting And AGM.Aug 08, 2024
Aug 08, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2024
Jul 31, 2024Announcement under Regulation 30 (LODR)-Change in ManagementJul 30, 2024
Jul 30, 2024Unaudited Financial Results For The Quarter Ended June 30, 2024Jul 30, 2024
Jul 30, 2024Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th July 2024Jul 30, 2024
Jul 30, 2024Board Meeting Intimation for Regulation 29 Of The SEBI (LODR) Reg, 2015Jul 23, 2024
Jul 23, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Jul 11, 2024Closure of Trading WindowJun 27, 2024
Jun 27, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 26, 2024
Jun 26, 2024Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 26, 2024
Jun 26, 2024Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, ('SEBI Listing Regulations') - Outcome Of The Board Meeting Of Medinova Diagnostic Services Limited Held On Wednesday, June 26, 2024Jun 26, 2024
Jun 26, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateJun 21, 2024
Jun 21, 2024Announcement under Regulation 30 (LODR)-Change in ManagementJun 01, 2024
Jun 01, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateApr 29, 2024
Apr 29, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 27, 2024
Apr 27, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateApr 26, 2024
Apr 26, 2024Announcement under Regulation 30 (LODR)-RetirementApr 26, 2024
Apr 26, 2024Audited Financial Results For The Quarter And Financial Year Ended 31St March 2024Apr 26, 2024
Apr 26, 2024Board Meeting Outcome for Outcome Of Board Meeting Held On 26Th April 2024Apr 26, 2024
Apr 26, 2024Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2024Apr 19, 2024
Apr 19, 2024Compliance Certificate For The Financial Year Ended March 31, 2024Apr 08, 2024
Apr 08, 2024Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31St March 2024Apr 04, 2024
Apr 04, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 03, 2024
Apr 03, 2024Closure of Trading WindowMar 22, 2024
Mar 22, 2024Technical Indicators
RSI(14)
Neutral 51.62
ATR(14)
Less Volatile 2.39
STOCH(9,6)
Neutral 38.04
STOCH RSI(14)
Neutral 71.56
MACD(12,26)
Bullish 0.15
ADX(14)
Weak Trend 15.41
UO(9)
Bearish 52.95
ROC(12)
Uptrend And Accelerating 4.22
WillR(14)
Neutral -63.12
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
